Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Rhoclone Anti Rh D Immunoglobulin (300mcg) Injection:
Rhoclone Anti Rh D Immunoglobulin (300mcg) Injection is a specialized immunoglobulin designed to prevent Rh immunization in Rh-negative individuals. This product is essential in preventing complications such as hemolytic disease of the newborn (HDN) caused by Rh incompatibility between the mother and fetus.
Uses of Rhoclone Anti Rh D Immunoglobulin (300mcg) Injection:
Prevention of Rh immunization in Rh-negative pregnant women
Management of Rh-negative individuals exposed to Rh-positive blood
Prevention of hemolytic disease of the newborn (HDN)
Benefits of Rhoclone Anti Rh D Immunoglobulin (300mcg) Injection:
Provides effective protection against Rh immunization
Reduces the risk of hemolytic disease of the newborn (HDN)
Safe and reliable with minimal adverse effects
Trusted and recommended by healthcare professionals globally
Mechanism of Action of Rhoclone Anti Rh D Immunoglobulin (300mcg) Injection:
Rhoclone Anti Rh D Immunoglobulin contains antibodies against the Rh D antigen. When administered, these antibodies target and neutralize any Rh-positive red blood cells present in the Rh-negative individuals bloodstream. This prevents the immune system from recognizing these cells as foreign and mounting an immune response, thereby avoiding Rh immunization and its associated complications, such as hemolytic disease of the newborn (HDN).